rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Christopher DelOrefice

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Ulta Beauty; EVP & Chief Financial Officer, Becton, Dickinson and; Director, ResMed.

In numbers

Trades disclosed
31
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
1
First trade
7 Sep 2021
Last trade
31 Mar 2026
Last filed
2 Apr 2026

Companies traded

Where they are an officer
ULTA Ulta BeautyOfficer · Retail — Specialty · last 31 Mar 20260 buys · 0 sells
BDX Becton, Dickinson andOfficer · Medical Devices · last 26 Nov 20250 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
RMD ResMedDirector · Medical Devices · last 20 Nov 20250 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
31 Mar 2026filed 2 Apr 2026ULTA Ulta BeautyRetail — SpecialtySEC FORM 4 Code A—4,219 at $0.00filing
31 Mar 2026filed 2 Apr 2026ULTA Ulta Beautyoption or derivative · Retail — SpecialtySEC FORM 4 Code A—14,363 at $0.00filing
31 Mar 2026filed 2 Apr 2026ULTA Ulta Beautyoption or derivative · Retail — SpecialtySEC FORM 4 Code A—14,363 at $0.00filing
31 Mar 2026filed 2 Apr 2026ULTA Ulta BeautyRetail — SpecialtySEC FORM 4 Code A—4,219 at $0.00filing
9 Dec 2025filed 10 Dec 2025ULTA Ulta BeautyRetail — SpecialtySEC FORM 4 Code A—1,825 at $0.00filing
9 Dec 2025filed 10 Dec 2025ULTA Ulta BeautyRetail — SpecialtySEC FORM 4 Code A—3,649 at $0.00filing
26 Nov 2025filed 1 Dec 2025BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—6,006 at $0.00filing
26 Nov 2025filed 1 Dec 2025BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code F—4,245 at $0.00filing
20 Nov 2025filed 24 Nov 2025RMD ResMedMedical DevicesSEC FORM 4 Code A—1,073 at $0.00filing
1 Sep 2025filed 2 Sep 2025BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code F—278 at $0.00filing
26 Nov 2024filed 29 Nov 2024BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A—19,138 at $0.00filing
26 Nov 2024filed 29 Nov 2024BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—4,884 at $0.00filing
26 Nov 2024filed 29 Nov 2024BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—9,015 at $0.00filing
26 Nov 2024filed 29 Nov 2024BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code F—5,192 at $0.00filing
20 Nov 2024filed 22 Nov 2024RMD ResMedMedical DevicesSEC FORM 4 Code A—1,083 at $0.00filing
7 Sep 2024filed 9 Sep 2024BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code F—466 at $0.00filing
3 Sep 2024filed 5 Sep 2024RMD ResMedMedical DevicesSEC FORM 4 Code A—267 at $0.00filing
1 Sep 2024filed 4 Sep 2024BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code F—254 at $0.00filing
26 Nov 2023filed 28 Nov 2023BDX Becton, Dickinson andoption or derivative · Medical DevicesSEC FORM 4 Code A—18,425 at $0.00filing
26 Nov 2023filed 28 Nov 2023BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—3,325 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Michael FeldEVP, Chief Revenue Officer · EVP, Chief Revenue Officer at Becton Dickinson & Co, filing Form 4 there in the last year
Kecia SteelmanPresident and CEO · President and CEO at Ulta Beauty, filing Form 4 there in the last year
Lorna NaglerDirector · Director at Ulta Beauty, filing Form 4 there in the last year
Kelly E. GarciaChief Technology Officer · Chief Technology Officer at Ulta Beauty, filing Form 4 there in the last year
Vitor RoqueEVP & Chief Financial Officer · EVP & Chief Financial Officer at Becton Dickinson & Co, filing Form 4 there in the last year